Latest 10-K annual reports
NASDAQ
GCTK
Glucotrack, INCGlucotrack Inc.'s latest 10-K filing highlights the company's focus on developing its implantable continuous blood glucose monitor (CBGM) while navigating financial uncertainties and Nasdaq compliance.
HCM II Acquisition Corp.'s latest filing details its share structure, warrant terms, and insider trading policies as it seeks a business combination.
NASDAQ
Tavia Acquisition Corp.'s 10-K filing details the company's focus on sustainable innovation, potential business combination targets, and associated risks.
10-K: Soho House & Co Inc. Navigates Economic Headwinds While Expanding Global Footprint: 2024 10-K Filing
Soho House & Co Inc.'s 2024 10-K filing reveals a year of revenue growth tempered by economic challenges and strategic investments in global expansion and digital platforms.
NASDAQ
Reading International's 10-K filing reveals a year of navigating Hollywood strikes, rising interest rates, and increased operating costs, balanced by strategic real estate sales and a focus on enhancing cinema experiences.
AMEX
CPI Aerostructures reports a net income of $3.3 million for 2024, despite a slight revenue decrease, driven by strategic cost management and a focus on high-value contracts.
1847 Holdings LLC's 2024 10-K filing reveals significant losses and a going concern warning, despite increased revenues in the construction segment.
OID
FDCT
Fdctech, INCFDCTech's 2024 annual report reveals a significant revenue increase driven by strategic acquisitions in wealth management and brokerage, alongside ongoing technology development.
NYSE
Resolute Holdings Management, Inc. files its annual report on Form 10-K, detailing its business strategy, management agreement with CompoSecure Holdings, and financial results.
AMEX
Battalion Oil Corp's FY24 results reveal a net loss amid strategic shifts, including debt refinancing and a terminated merger, while focusing on operational efficiencies and liquidity.
NASDAQ
LM Funding America's 2024 10-K filing reveals a year of strategic shifts, including expansion in Bitcoin mining and continued operation in specialty finance, amid fluctuating market conditions and financial adjustments.
NASDAQ
Brand Engagement Network Inc. reports a significant net loss for 2024 while strategically focusing on expanding its AI capabilities and market presence through acquisitions and partnerships.
NASDAQ
Opus Genetics provides an update on its financial standing, gene therapy pipeline advancements, and strategic partnerships in its annual 10-K filing.
NASDAQ
Voyager Acquisition Corp.'s 10-K filing outlines the company's share structure, warrant details, and governance policies as of December 31, 2024.
OTC.Pink
MMTRS
Mills Music TrustMills Music Trust's 2024 annual report reveals ongoing disputes with EMI over royalty payments and highlights key financial data and copyright information.
Gryphon Digital Mining's 2024 annual report reveals a strategic shift towards acquiring energy assets for AI and high-performance computing (HPC) while navigating challenges in the Bitcoin mining market.
NASDAQ
Nuvve Holding Corp. files its 10-K report for the year ended December 31, 2024, detailing its V2G technology, financial performance, and strategic outlook.
NYSE
Maui Land & Pineapple Company reports its 2024 financial results, highlighting a strategic shift towards land development and community building on Maui.
NASDAQ
CNS Pharmaceuticals' 10-K filing reveals a year of strategic shifts, focusing on TPI 287 development and analyzing the path forward after topline data from the Berubicin trial did not meet its primary endpoint.
OQB
BUDZ
Weed, INCWEED, Inc.'s 10-K filing reveals ongoing efforts in cannabis research and development, underscored by persistent financial constraints and a need for additional funding.
NASDAQ
10-K: bioAffinity Technologies Reports Increased Revenue, Outlines Strategic Actions in Annual 10-K Filing
bioAffinity Technologies' 10-K filing reveals a 270% revenue increase driven by the PPLS acquisition, alongside strategic cost-saving measures and continued focus on CyPath Lung commercial growth.
NASDAQ
CytoSorbents Corporation files its 2024 10-K, highlighting revenue growth, reduced operating losses, and progress towards regulatory approval for DrugSorb-ATR.
LQR House Inc.'s 2024 annual report reveals substantial net losses and raises concerns about the company's ability to continue as a going concern, despite increased revenue and strategic acquisitions.
OTC.Pink
Crown Electrokinetics Corp. reports a significant revenue increase driven by its Fiber Optics and Water Solutions divisions, but faces challenges including a Nasdaq delisting and ongoing financial losses.
OTC.Pink
Miami Breeze Car Care Inc. reports a net loss for 2024 and announces the acquisition of Gin City Group, a luxury lifestyle company.
AMEX
PED
Pedevco CORPPEDEVCO Corp. files its 10-K for fiscal year 2024, including restated financial statements for 2022 and 2023 due to an error in calculating depletion expense.
Leafly Holdings reports a net loss for 2024, grapples with delisting from Nasdaq, and expresses substantial doubt about its ability to continue as a going concern.
New Era Helium Inc. aims to become a leading helium and natural gas supplier, transitioning from a hydrocarbon focus to a helium-centric model with the construction of its Pecos Slope Plant.
Amaze Holdings, formerly Fresh Vine Wine, reports a significant decrease in revenue for FY2024, navigates a recent acquisition, and addresses concerns about its ability to continue as a going concern.
ICAD
Icad INCiCAD Inc. reports a 13.2% increase in revenue for 2024, driven by growth in product and license sales and strategic initiatives.